Search - tctmd.com

Displaying 21 - 40 of 92

Sort: Relevancy | Date

Video

» Interview

Treatment of AS in Young Patients

June 24, 2024

Video

» Interview

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo Versus the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

September 18, 2022

Video

» Topical Discussion

The Impact of Valve Flow Dynamics on Disease Regression and Outcomes After TAVR

November 18, 2024

Video

» Topical Discussion

The ARTIST Study and the Future of TAVR for Aortic Regurgitation

December 5, 2024

Video

» Topical Discussion

TAVR in 2019: Appropriate Metrics for Success

March 21, 2019

Video

TAVR for Aortic Regurgitation: The Completion of the ALIGN-AR Study and the Future Paradigm of AR Treatment

October 6, 2022

Video

» Talking TAVR

Talking TAVR: OBSERVANT

January 9, 2019

Video

» Talking TAVR

Talking TAVR - TAVR/LAAO

January 9, 2019

Video

» On Record

Taking the Long View on Aortic Stenosis

June 28, 2023

Video

» Topical Discussion

Studying the Clinical Impact of Restoring Native Flow

October 9, 2024

Video

» Live Case

Structural Live - Transcatheter Aortic Valve Replacement Bicuspid

November 10, 2025

Video

» Live Case

Structural Live - Live Case Transcatheter Aortic Valve Replacement with Leaflet Modification

November 10, 2025

Video

» Topical Discussion

ShortCut™️: The Only FDA-Cleared Leaflet Modification Solution for Streamlining Complex TAVR Procedures

October 24, 2024

Video

SHDS 2018: Point: TAVR will be the Treatment of Choice for Bicuspid Aortic Valve Disease in the Future!

June 26, 2018

Video

SHDS 2018: Multisociety Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Useful Guide for Clinical Decision-Making?

June 26, 2018

Video

SHDS 2018: Keynote Lecture #2: Useful and Evolving Biomarkers In Aortic Stenosis and TAVR - Current Status and Future Directions

July 4, 2018

Video

SHDS 2018: Early Commercial Experience Using the PORTICO Transcatheter Aortic Valve: 30-Day Outcomes in 973 Patients Enrolled in the Portico I Study (Cohort A)

July 4, 2018

Video

SHDS 2018: Counterpoint: Most Bicuspid Aortic Valves (Especially In Younger Low-Risk Patients) Will Remain in the Surgical Domain!

June 26, 2018

Video

SHDS 2018: An Introduction to “VARC-3: A Focused Update” – New Endpoints and Definitions for Aortic Valve Clinical Research

June 26, 2018

Video

» Topical Discussion

Quick Takes: Marwan Saad on the Clinical Implications of PROTECTED TAVR

April 2, 2025

Advertisement

Treatment of AS in Young Patients

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo Versus the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

The Impact of Valve Flow Dynamics on Disease Regression and Outcomes After TAVR

The ARTIST Study and the Future of TAVR for Aortic Regurgitation

TAVR in 2019: Appropriate Metrics for Success

TAVR for Aortic Regurgitation: The Completion of the ALIGN-AR Study and the Future Paradigm of AR Treatment

Talking TAVR: OBSERVANT

Talking TAVR - TAVR/LAAO

Taking the Long View on Aortic Stenosis

Studying the Clinical Impact of Restoring Native Flow

Structural Live - Transcatheter Aortic Valve Replacement Bicuspid

Structural Live - Live Case Transcatheter Aortic Valve Replacement with Leaflet Modification

ShortCut™️: The Only FDA-Cleared Leaflet Modification Solution for Streamlining Complex TAVR Procedures

SHDS 2018: Point: TAVR will be the Treatment of Choice for Bicuspid Aortic Valve Disease in the Future!

SHDS 2018: Multisociety Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Useful Guide for Clinical Decision-Making?

SHDS 2018: Keynote Lecture #2: Useful and Evolving Biomarkers In Aortic Stenosis and TAVR - Current Status and Future Directions

SHDS 2018: Early Commercial Experience Using the PORTICO Transcatheter Aortic Valve: 30-Day Outcomes in 973 Patients Enrolled in the Portico I Study (Cohort A)

SHDS 2018: Counterpoint: Most Bicuspid Aortic Valves (Especially In Younger Low-Risk Patients) Will Remain in the Surgical Domain!

SHDS 2018: An Introduction to “VARC-3: A Focused Update” – New Endpoints and Definitions for Aortic Valve Clinical Research

Quick Takes: Marwan Saad on the Clinical Implications of PROTECTED TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content